arrow
J

Jing Chen

Shanghai Institute of Cardiovascular Diseases
H指数:27
被引数:2,699

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Engineered macrophage membrane fusion liposomes carrying siRNA for spatiotemporal regulation of the CCL2/CCR2 axis for cardiac repair

工程化巨噬细胞膜融合脂质体携带siRNA,用于空间-时间调控CCL2/CCR2轴以实现心脏修复

2025-08-050
PRE
Biomimetic Nano-Degrader Based CD47-SIRPα Immune Checkpoint Inhibition Promotes Macrophage Efferocytosis for Cardiac Repair

基于仿生纳米降解剂的cd47-sirp α 免疫检查点抑制促进巨噬细胞胞吞作用的心脏修复

2024-03-132
OA
Genetically Engineered Macrophages Co-Loaded with CD47 Inhibitors Synergistically Reconstruct Efferocytosis and Improve Cardiac Remodeling Post Myocardial Ischemia Reperfusion Injury

基因工程巨噬细胞共负载CD47抑制剂协同重建胞吞作用并改善心肌缺血再灌注损伤后的心脏重构

2024-03-136
OAAI
Hippo pathway-manipulating neutrophil-mimic hybrid nanoparticles for cardiac ischemic injury via modulation of local immunity and cardiac regeneration

Hippo途径操纵中性粒细胞模拟杂化纳米颗粒通过调节局部免疫和心脏再生来治疗心脏缺血性损伤

2023-12-013
OAAI
Precisely co-delivery of protein and ROS scavenger with platesomes for enhanced endothelial barrier preservation against myocardial ischemia reperfusion injury

蛋白质和ROS清除剂与platesomes的精确共递送,以增强对心肌缺血再灌注损伤的内皮屏障保护

2022-10-0111
PRE
Platelet-Like Fusogenic Liposome-Mediated Targeting Delivery of miR-21 Improves Myocardial Remodeling by Reprogramming Macrophages Post Myocardial Ischemia-Reperfusion Injury

血小板样融合脂质体介导的miR-21靶向递送通过重编程巨噬细胞改善心肌缺血再灌注损伤后的心肌重塑

2021-06-1776
OAAI